M516102

Maruho Co., Ltd. · Phase 2 active Small molecule

At a glance

Generic name	M516102
Sponsor	Maruho Co., Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

M516102 CI brief — competitive landscape report
M516102 updates RSS · CI watch RSS
Maruho Co., Ltd. portfolio CI